Delivery Order SPE2DB22D2206-SPE2DB24FFN63
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $39K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $15,836.43 and a performance period through May 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $15,622.39 and a completion date of March 5, 2024. The contract is a firm fixed-price, open competition award with no set-aside designation. Amerisourcebergen holds a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract provides for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, to support military treatment programs and facilities. The award has a ceiling value of $2,666.24 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML. The contract has a ceiling value of $8,513.40 and a period of performance through May 8, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $2,805.52 and a period of performance through May 16, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,122.56, is for the provision of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 14, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $96,723.41, is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 6, 2022 and is a Firm Fixed Price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML. The contract has a ceiling value of $5,729.40 and an ultimate completion date of May 13, 2025. The contract is not set-aside and was awarded on May 12, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $28,876.52 and a performance period ending on May 21, 2025. The contract is a Firm Fixed Price, Delivery Order type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,295,500 units of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has a ceiling value of $11,195.24 and is structured as a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...